Background: Mutations in the genes called BRCA1 and BRCA2 are associated with significantly elevated lifetime risk of developing breast and ovarian cancer. This year marks 25 years since genetic tests for BRCA1/2 mutations became available to the public. Currently. comprehensive guidelines exist regarding BRCA1/2 testing and preventive measures in mutation carriers. https://mabelandfoxs.shop/product-category/animals/